Immune‐related adverse events are associated with improved response, progression‐free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors
Foster, Corey C., Couey, Marcus A., Kochanny, Sara E., Khattri, Arun, Acharya, Rajesh K., Tan, Yi‐Hung Carol, Brisson, Ryan J., Leidner, Rom S., Seiwert, Tanguy Y.
Published in Cancer (15.12.2021)
Published in Cancer (15.12.2021)
Get full text
Journal Article
A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma
Kochanny, Sara E., Worden, Francis P., Adkins, Douglas R., Lim, Dean W., Bauman, Julie E., Wagner, Stephanie A., Brisson, Ryan J., Karrison, Theodore G., Stadler, Walter M., Vokes, Everett E., Seiwert, Tanguy Y.
Published in Cancer (15.05.2020)
Published in Cancer (15.05.2020)
Get full text
Journal Article
Abstract A085: Racial differences in organ preservation with definitive chemoradiotherapy among patients with T4 laryngeal squamous cell carcinoma
Hara, Jared H., Freeman, Jason Q., Kochanny, Sara E., Ecanow, Naomi S., Rosenberg, Ari J., Pearson, Alexander T., Gooi, Zhen, Baird, Brandon J., Blair, Elizabeth A., Agrawal, Nishant, Vokes, Everett E., Haraf, Daniel J., Juloori, Aditya
Published in Cancer epidemiology, biomarkers & prevention (01.01.2023)
Published in Cancer epidemiology, biomarkers & prevention (01.01.2023)
Get full text
Journal Article